StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMJul 13, 2026, 04:32 PM

BGM Group EGM Approves Share Consolidation, Capital Increase, M&A Changes

AI Summary

BGM Group Ltd. announced the results of its Extraordinary General Meeting held on July 9, 2026. A quorum was met with 245,400,111 ordinary shares represented. All resolutions presented to the shareholders were duly passed, authorizing the board to proceed with a share consolidation, capital increase, and amendments to the company's M&A documents, among other actions. These authorizations are valid for a period of 3 calendar years.

Key Highlights

  • Extraordinary General Meeting held on July 9, 2026, at 9:00 p.m. ET.
  • 245,400,111 ordinary shares were present or by proxy, constituting a quorum.
  • All resolutions presented to shareholders were duly passed.
  • Board authorized to set Share Consolidation ratio within a defined range.
  • Board authorized to implement Post-Share Consolidation Share Capital Increase.
  • Board authorized to adopt New M&A upon each Share Consolidation and Capital Increase.
  • Board authorized to effect Share Capital Reduction and Reorganization.
  • Board authorized to amend Existing M&A, subject to Cayman Islands law.